Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quetiapine plus SSRI in treatment-resistant depression: possible mechanisms.

× No keyword cloud information.

12 in total

1. Pharmacologic management of refractory depression.

Authors: S Chehil; S Devarajan; S M Dursun
Journal: Can Fam Physician Date: 2001-01 Impact factor: 3.275

2. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.

Authors: A L Sharpley; C M Vassallo; P J Cowen
Journal: Biol Psychiatry Date: 2000-03-01 Impact factor: 13.382

3. Olanzapine plus venlafaxine in treatment-resistant depression.

Authors: S Devarajan; S M Dursun
Journal: J Psychopharmacol Date: 2005-07 Impact factor: 4.153

4. Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.

Authors: Ann L Sharpley; Mary E J Attenburrow; Sepehr Hafizi; Philip J Cowen
Journal: J Clin Psychiatry Date: 2005-04 Impact factor: 4.384

5. Metabolic mechanism of quetiapine in vivo with clinical therapeutic dose.

Authors: K-Y Li; X Li; Z-N Cheng; H-D Li
Journal: Methods Find Exp Clin Pharmacol Date: 2005-03

6. A novel augmentation strategy for treating resistant major depression.

Authors: R C Shelton; G D Tollefson; M Tohen; S Stahl; K S Gannon; T G Jacobs; W R Buras; F P Bymaster; W Zhang; K A Spencer; P D Feldman; H Y Meltzer
Journal: Am J Psychiatry Date: 2001-01 Impact factor: 18.112

Review 7. Metabolic interactions of central nervous system medications and selective serotonin reuptake inhibitors.

Authors: C A Naranjo; B A Sproule; D M Knoke
Journal: Int Clin Psychopharmacol Date: 1999-05 Impact factor: 1.659

Review 8. Advances in psychopharmacology: mood disorders and dementia.

Authors: P J Cowen
Journal: Br Med Bull Date: 1996-07 Impact factor: 4.291

9. The 'dalhousie serotonin cocktail' for treatment-resistant major depressive disorder.

Authors: S M Dursun; S Devarajan; S Kutcher
Journal: J Psychopharmacol Date: 2001-06 Impact factor: 4.153

10. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.

Authors: John D Matthews; Kathryn A Bottonari; Laura M Polania; David Mischoulon; Christina M Dording; Robert Irvin; Maurizio Fava
Journal: J Clin Psychiatry Date: 2002-12 Impact factor: 4.384

3 in total

1. Quetiapine augmentation in treatment-resistant depression: a naturalistic study.

Authors: Marina Sagud; Alma Mihaljević-Peles; Dorotea Mück-Seler; Miro Jakovljević; Nela Pivac
Journal: Psychopharmacology (Berl) Date: 2006-06-27 Impact factor: 4.530

Review 2. Therapeutic options for treatment-resistant depression.

Authors: Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal: CNS Drugs Date: 2010-02 Impact factor: 5.749

3. A review of quetiapine in combination with antidepressant therapy in patients with depression.

Authors: Ella J Daly; Madhukar H Trivedi
Journal: Neuropsychiatr Dis Treat Date: 2007-12 Impact factor: 2.570

3 in total